Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Discovery Labs Reports Third Quarter 2013 Financial Results
Yahoo
Wednesday, November 13, 2013 - 8:25am
tags:
Discovery Labs, earnings
J&J Said to Reach $4 Billion Deal to Settle Hip Lawsuits
Bloomberg
Tuesday, November 12, 2013 - 4:55pm
tags:
JNJ, hip implants, devices, recalls, DePuy
J&J's Velcade gets stiff-armed at NICE as first-line myeloma treatment
Fierce Pharma
Tuesday, November 12, 2013 - 4:37pm
tags:
JNJ, Velcade, Multiple Myeloma
Actavis to shed 310 jobs in shutdown of NC plant
Fierce Pharma
Tuesday, November 12, 2013 - 4:34pm
tags:
Actavis, drug manufacturing, layoffs
What The Delay Of A Promising Muscular Dystrophy Drug Means For Patients, Investors And All Of Biotech
Forbes
Tuesday, November 12, 2013 - 4:32pm
tags:
Duchenne Muscular Dystrophy, eteplirsen, Sarepta Therapeutics
Medivation Reports Third Quarter Financial Results and Provides Corporate Update
Yahoo
Tuesday, November 12, 2013 - 4:28pm
tags:
Medivation, earnings
Is Arena Pharmaceuticals Making Progress?
Daily Finance
Tuesday, November 12, 2013 - 1:13pm
tags:
Arena Pharmaceuticals, Belviq, obesity, Eisai
Shire Acquires Viropharma: Two Winners In This Deal
Seeking Alpha
Tuesday, November 12, 2013 - 1:11pm
tags:
Shire, ViroPharma, M&A
Gilead Five-year Revenue Outlook, Part 1
Seeking Alpha
Tuesday, November 12, 2013 - 1:10pm
tags:
Gilead Sciences
Biogen’s Hemophilia Drug Delay May Push Sales to Mid-2014
Bloomberg
Tuesday, November 12, 2013 - 1:09pm
tags:
hemophilia, Biogen Idec, Eloctate
Ohr Pharma: A Pure 2014 Catalyst Play With Large Potential
Seeking Alpha
Tuesday, November 12, 2013 - 1:08pm
tags:
Ohr Pharmaceutical, wet-AMD, Squalamine Eye Drops, ovarian cancer
Endo Tax Edge for Deals Mimics Valeant Playbook: Real M&A
Bloomberg
Tuesday, November 12, 2013 - 11:04am
tags:
Endo Health Solutions, M&A, Valeant Pharmaceuticals
Will Galena Biopharma Triple Soon?
Wall St Cheat Sheet
Tuesday, November 12, 2013 - 10:06am
tags:
Galena Biopharma, Abstral
Home healthcare provider Amedisys reports quarterly loss
Reuters
Tuesday, November 12, 2013 - 9:56am
tags:
earnings, home healthcare, Amedisys
Boston Scientific's anti-stroke Watchman heart implant lands a date with the FDA
Mass Device
Tuesday, November 12, 2013 - 9:54am
tags:
Boston Scientific, stroke, WATCHMAN, devices
Glaxo’s Darapladib Fails to Prevent Heart Attacks in Test
Bloomberg
Tuesday, November 12, 2013 - 9:53am
tags:
GSK, darapladib, heart attacks
Sanofi Files 'First-Of-A-Kind' Lawsuit Against FDA Over OTC Drug
Pharmalot
Tuesday, November 12, 2013 - 9:50am
tags:
Sanofi, FDA, OTC, Nasacort
Gentium announces completion of defibrotide Phase 1 study in Japan
The Fly on the Wall
Tuesday, November 12, 2013 - 9:48am
tags:
Defibrotide, Japan, Gentium
Why You Should Be Watching Sarepta, Hologic, and Achillion Today
Motley Fool
Tuesday, November 12, 2013 - 9:41am
tags:
Achillion, Sarepta Therapeutics, Hologic, earnings, eteplirsen
A.P. Pharma Announces Pipeline Expansion
Yahoo
Tuesday, November 12, 2013 - 9:21am
tags:
AP Pharma, Sustol

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.